Joshua David Lee MD
Addiction Medicine
Assistant Professor, Population Health, New York University School of Medicine
Join to View Full Profile
Bellevue Hospital460 First AveNew York, NY 10016
Phone+1 212-562-3000
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineResidency, Internal Medicine, 1999 - 2003
University of Tennessee Health Science Center College of MedicineClass of 1999
Certifications & Licensure
NY State Medical License 2001 - 2026
American Board of Preventive Medicine Addiction Medicine
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Clinical Trials
- Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail Start of enrollment: 2010 May 01
- Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT...Sara Lodi, Shapei Yan, Benjamin Bovell-Ammon, Paul J Christine, Heather E Hsu
Addiction. 2025-03-19 - 2 citationsTarget trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder.Paul J Christine, Sara Lodi, Heather E Hsu, Benjamin Bovell-Ammon, Shapei Yan
Addiction. 2024-07-01 - Jail-based medication for opioid use disorder and patterns of reincarceration and acute care use after release: A sequence analysis.Sungwoo Lim, Teena Cherian, Monica Katyal, Keith S Goldfeld, Ryan McDonald
Journal of Substance Use and Addiction Treatment. 2024-03-01
Journal Articles
- Cost-Effectiveness of Buprenorphine–Naloxone Versus Extended-Release Naltrexone to Prevent Opioid RelapseJoshua D Lee, John Rotrosen, Edward V Nunes, Annals of Internal Medicine
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
